Gain Therapeutics Ownership | Who Owns Gain Therapeutics?


OverviewForecastFinancialsChart

Gain Therapeutics Ownership Summary


Gain Therapeutics is owned by 15.88% institutional investors, 3.40% insiders, and 80.72% retail investors. Potomac capital management is the largest institutional shareholder, holding 2.89% of GANX shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.96% of its assets in Gain Therapeutics shares.

GANX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockGain Therapeutics15.88%3.40%80.72%
SectorHealthcare Stocks 232.63%10.66%-143.29%
IndustryBiotech Stocks 382.12%10.42%-292.54%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Potomac capital management1.01M2.89%$3.25B
Jones financial companies lllp676.82K2.23%$1.21M
Dme capital management, lp566.13K1.87%$1.00M
Hohimer wealth management330.00K1.84%$422.40K
Vanguard group569.90K1.63%$1.84M
Cambridge investment research advisors568.64K1.62%$1.83M
Geode capital management397.94K1.14%$1.28M
Jane street group242.33K0.69%$780.30K
Blackrock funding, inc. /de209.58K0.60%$674.84K
Marshall wace, llp175.11K0.58%$309.94K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Potomac capital management1.01M2.61%$3.25B
Hohimer wealth management330.00K0.10%$422.40K
Dme capital management, lp566.13K0.04%$1.00M
Benedict financial advisors38.00K0.03%$122.36K
Oliver luxxe assets20.25K0.01%$65.20K
Two sigma securities27.32K0.01%$48.36K
Gsa capital partners llp20.47K0.01%$66.00K
Virtu financial54.01K0.01%$96.00K
Xtx topco54.20K0.01%$95.94K
Prelude capital management35.82K0.00%$63.40K

Top Buyers

HolderShares% AssetsChange
Potomac capital management1.01M2.61%1.01M
Hohimer wealth management330.00K0.10%330.00K
Cambridge investment research advisors568.64K0.00%250.00K
Jane street group242.33K0.00%169.88K
Lpl financial106.55K0.00%106.55K

Top Sellers

HolderShares% AssetsChange
Timelo investment management---605.29K
Alyeska investment group---450.00K
Raymond james & associates---260.02K
Gotham asset management---245.90K
Cable car capital---145.00K

New Positions

HolderShares% AssetsChangeValue
Potomac capital management1.01M2.61%1.01M$3.25B
Hohimer wealth management330.00K0.10%330.00K$422.40K
Lpl financial106.55K0.00%106.55K$343.09K
Xtx topco54.20K0.01%54.20K$95.94K
Susquehanna group, llp46.91K-46.91K$101.33K

Sold Out

HolderChange
Hm payson-1.00K
Citigroup-2.00K
Raymond james financial-2.30K
Citadel advisors-2.50K
Srs capital advisors-3.25K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202532-17.95%5,557,14228.00%157.76%244.35%3-25.00%
Sep 30, 202519-44.12%2,622,446-26.12%86.32%10-37.50%2-50.00%
Jun 30, 2025362.86%3,787,85934.77%1213.00%17-22.73%5150.00%
Mar 31, 20253529.63%2,384,40620.20%814.87%2116.67%350.00%
Dec 31, 202410-50.00%683,297-59.21%26.46%6-33.33%1-75.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr371.15K0.96%-
Fidelity Extended Market Index192.98K0.50%1.82K
BANOR SICAV Rosemary S EUR Acc120.00K0.31%-1.59K
Blackrock Extended Mkt Fund CF119.89K0.31%119.89K
Extended Equity Market Fund K102.83K0.27%66.90K
iShares Micro-Cap ETF90.45K0.24%66.26K
Fidelity Total Market Index57.34K0.15%-
Spartan Extended Market Index Pool F56.89K0.15%18.50K
BlackRock Extended Equity Market K36.53K0.14%-16.00
Fidelity Series Total Market Index52.22K0.14%9.35K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 09, 2024Mack Gene CFO and Interim CEOBuy$14.54K
Aug 09, 2024Islam Khalid Executive ChairmanBuy$49.94K
Jul 01, 2024RICHMAN ERIC I-Buy$14.52K
Jul 01, 2024RICHMAN ERIC I-Buy$6.15K
Mar 28, 2024Riley Jeffrey Scott-Buy$115.77K

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1--
2024 Q34-
2024 Q2--
2024 Q11-

GANX Ownership FAQ


Who Owns Gain Therapeutics?

Gain Therapeutics shareholders are primarily institutional investors at 15.88%, followed by 3.40% insiders and 80.72% retail investors. The average institutional ownership in Gain Therapeutics's industry, Biotech Stocks , is 382.12%, which Gain Therapeutics falls below.

Who owns the most shares of Gain Therapeutics?

Gain Therapeutics’s largest shareholders are Potomac capital management (1.01M shares, 2.89%), Jones financial companies lllp (676.82K shares, 2.23%), and Dme capital management, lp (566.13K shares, 1.87%). Together, they hold 6.98% of Gain Therapeutics’s total shares outstanding.

Does Blackrock own Gain Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Gain Therapeutics.

Who is Gain Therapeutics’s biggest shareholder by percentage of total assets invested?

Potomac capital management is Gain Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.61% of its assets in 1.01M Gain Therapeutics shares, valued at 3.25B$.

Who is the top mutual fund holder of Gain Therapeutics shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Gain Therapeutics shares, with 0.96% of its total shares outstanding invested in 371.15K Gain Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools